We've detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser.GoogleFirefox
Sign In

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.

https://www.barrons.com/articles/pfizer-pfe-stock-earnings-guidance-51635850945

Pfizer Stock Charges Higher as Drug Maker Boosts 2021 Guidance

By
Joe Woelfel
  • Order Reprints
  • Print Article

Pfizer shares rose more than 4% in premarket trading Tuesday after the drug maker posted third-quarter adjusted earnings that topped analysts’ estimates and it raised fiscal 2021 guidance.

Pfizer reported adjusted earnings in the quarter of $1.34 a share on revenue of $24.1 billion.

Analysts surveyed by FactSet expected Pfizer (ticker: PFE)...

Copyright ©2021 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.